Delivery Order SPE2DR25D2006-SPE2DR26F56UN
- Not listed
- The Defense Logistics Agency awarded a $5,694.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10-count) on December 2, 2025, with completion due by December 3, 2025. This competitive award, which received no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for Oseltamivir Phosphate 75 mg capsules in unit dose packaging. The contract, valued at $1,099.36, represents a firm fixed price delivery order with an ultimate completion date of December 16, 2025. This award was not set aside for small business or other socioeconomic categories and was competitively awarded. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a $7,491.60 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packs of 10. This is a firm fixed-price contract with performance completion targeted for December 9, 2025, and will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency awarded a delivery order valued at $3,751.97 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 on December 11, 2025, with a completion date of December 12, 2025. This non-competitive delivery order represents a firm fixed price transaction performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency awarded a delivery order valued at $1,016.96 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. The award, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $2,280.08 delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10s. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 15, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a $9,988.80 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. This firm fixed price, non-set-aside contract is scheduled for ultimate completion on December 16, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules (100-count packages) with a ceiling value of $1,890.00. This firm fixed-price delivery order is set to be completed by December 12, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a competitive award with no set-aside designation, issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging. This contract, valued at $2,497.20 with a firm fixed price structure, represents a small delivery order with an ultimate completion date of December 16, 2025. The award carries no set-aside designation, indicating it was competitively awarded through open procurement processes. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. This contract, issued under a firm fixed-price delivery order structure, carries a ceiling value of $1,038.01 and is scheduled for completion by December 11, 2025. The award represents a non-competitive set-aside and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F56UNDelivery Order
The Defense Logistics Agency (DLA) awarded a $2,776.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10. The contract, which is a non-set-aside competitive award, is scheduled for completion by December 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, leveraging its comprehensive SPE2DX IDC vehicle to supply an extensive range of medications, vaccines, and medical supplies across multiple therapeutic domains. As the prime contractor on this delivery order, AmerisourceBergen demonstrates its established capability to fulfill federal medical procurement requirements through competitive contracting. The award of this Oseltamivir supply order supports the Defense Health Agency and other federal healthcare customers in maintaining adequate antiviral medication inventories for potential pandemic preparedness and seasonal influenza treatment needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 12/15/25 |